NCT07184450 - Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

September 30, 2028

Conditions

Juvenile Dermatomyositis (JDM)Polyarticular Juvenile Idiopathic ArthritisSystemic Sclerosis (SSc)Primary Sjogren's Syndrome

Interventions

BIOLOGICAL

BCMA/CD70-targetd CAR-T

Subjects underwent lymphocytetion cheotherapy and then received a single intravenous cell infusion

Trial Locations (1)

RECRUITING

Children's Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors

lead

Chongqing Precision Biotech Co., Ltd

INDUSTRY